Prachi Wickremasingha

Pharmacokinetics, safety, and tolerability of edoxaban in end-stage renal disease subjects undergoing haemodialysis

Thomas Marbury, Nobuko Matsushima, Shuquan Chen et al. · Thrombosis and Haemostasis · 2015 · 129 citations

Dialysis Therapy, Pharmacotherapy, Pharmacokinetics +23

The impact of a three-factor prothrombin complex concentrate on the anticoagulatory effects of the factor Xa inhibitor edoxaban

Karen Brown, Prachi Wickremasingha, Dolly A. Parasrampuria et al. · Thrombosis Research · 2015 · 31 citations · Full text

Lack of effect of colesevelam HCl on the single-dose pharmacokinetics of aspirin, atenolol, enalapril, phenytoin, rosiglitazone, and sitagliptin

Ling He, Prachi Wickremasingha, James Lee et al. · Diabetes Research and Clinical Practice · 2014 · 23 citations

Pharmacological Study, Single-dose Pharmacokinetics, Pharmacology +5

Lack of Effect of DX-619, a Novel Des-Fluoro(6)-Quinolone, on Glomerular Filtration Rate Measured by Serum Clearance of Cold Iohexol

Nenad Sarapa, Prachi Wickremasingha, Nanxiang Ge et al. · Antimicrobial Agents and Chemotherapy · 2007 · 18 citations · Full text

Healthy Subjects, Pharmacotherapy, Antimicrobial Chemotherapy +18

Quantitative Structure‐Property Relationships Modeling to Predict In Vitro and In Vivo Binding of Drugs to the Bile Sequestrant, Colesevelam (Welchol)

Joseph R. Walker, Karen Brown, Shashank Rohatagi et al. · The Journal of Clinical Pharmacology · 2009 · 17 citations

Pharmaceutical Science, Drug Target, Vivo Binding +18